- Assess degree and manifestations of anxiety and mental status (orientation, mood, behavior) prior to and periodically during therapy.
- Assess patient for drowsiness, light-headedness, and dizziness. These symptoms usually disappear as therapy progresses. Dose should be reduced if these symptoms persist.
- Geri: Assess CNS effects and risk of falls. Institute falls prevention strategies.
- Prolonged high-dose therapy may lead to psychological or physical dependence. Risk is greater in patients taking >4 mg/day. Restrict the amount of drug available to patient. Assess regularly for continued need for treatment.
Lab Test Considerations:
Monitor CBC and liver and renal function periodically during long-term therapy. May cause ↓ hematocrit and neutropenia.Toxicity Overdose:
Flumazenil is the antidote for alprazolam toxicity or overdose. (Flumazenil may induce seizures in patients with a history of seizures disorder or who are on tricyclic antidepressants").
ALPRAZolam has been found in Davis's Drug Guide
If you are a registered user, please login below.
If not, learn more about gaining full access.
- Try and Buy
- Nursing Central puts five fully integrated references at your fingertips on mobile devices and the web. See how Nursing Central works by clicking the sample entries below or purchase a subscription for the web and your mobile device.
View these free topics online now.